Michael John Sasse

Title: Michael John Sasse: Innovator in Pharmaceutical Chemistry

Introduction

Michael John Sasse is a notable inventor based in Tunbridge Wells, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of thiazolidinedione derivatives. With a total of 6 patents to his name, Sasse has established himself as a key figure in the industry.

Latest Patents

Among his latest patents is a substituted thiazolidinedione derivative, which includes a process for its preparation and its pharmaceutical use. This patent describes a hydrate of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione, maleic acid salt. Another significant patent focuses on a polymorphic form of the same compound, characterized by its unique infra red and Raman spectra, as well as solid-state nuclear magnetic resonance and X-ray powder diffraction patterns. These innovations highlight Sasse's commitment to advancing medical applications through his research.

Career Highlights

Michael John Sasse is currently associated with SmithKline Beecham Corporation, where he continues to work on groundbreaking pharmaceutical developments. His expertise in the field has led to numerous advancements that benefit the medical community.

Collaborations

Sasse has collaborated with esteemed colleagues such as Paul David James Blackler and David C Lee. These partnerships have fostered a collaborative environment that enhances innovation and research in pharmaceutical chemistry.

Conclusion

Michael John Sasse's contributions to the field of pharmaceutical chemistry are noteworthy. His innovative patents and collaborations reflect his dedication to improving medical treatments through scientific research.